BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/20/2014 6:38:00 PM | Browse: 399 | Download: 309
Publication Name World Journal of Gastroenterology
Manuscript ID 7281
Country of Manuscript Source United States
Received
2013-11-12 14:51
Peer-Review Started
2013-11-13 11:45
To Make the First Decision
2013-12-26 10:49
Return for Revision
2013-12-27 15:08
Revised
2014-01-24 03:18
Second Decision
2014-04-03 10:15
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-04-03 12:33
Articles in Press
2014-05-23 09:56
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-08-06 11:58
Publish the Manuscript Online
2014-08-20 18:38
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Specialty Transplantation
Manuscript type Topic Highlights
Article Title Cytomegalovirus infection in liver transplant recipients: Updates on clinical management
Manuscript Source Invited Manuscript
All Author List Jasmine Riviere Marcelin, Elena Beam and Raymund R Razonable
Funding Agency and Grant Number
Corresponding author Raymund R Razonable, MD, Division of Infectious Diseases, Department of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, United States. razonable.raymund@mayo.edu
Keywords Cytomegalovirus; Liver transplantation; Valganciclovir; Prophylaxis; Treatment; Resistance; Investigational; Letermovir; Brincidofovir
Core Tip In this article, the authors review the current literature of cytomegalovirus (CMV) infection after liver transplantation, including the approaches to diagnosis, prevention and treatment. The review highlights the pros and cons of the prophylaxis vs pre-emptive prevention strategies, especially in the highest risk D+/R- population. Treatment of CMV infection in liver transplant patients is discussed in addition to management of CMV resistance, with detailed discussion of recently updated clinical CMV management guidelines. Finally, the future management of CMV in liver transplant recipients relies on new drug discoveries, and the authors describe multiple investigational drugs and vaccines in clinical trials.
Publish Date 2014-08-20 18:38
Citation Marcelin JR, Beam E, Razonable RR. Cytomegalovirus infection in liver transplant recipients: Updates on clinical management. World J Gastroenterol 2014; 20(31): 10658-10667
Url http://www.wjgnet.com/1007-9327/full/v20/i31/10658.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i31.10658
Full Article (PDF) WJG-20-10658.pdf
Full Article (Word) WJG-20-10658.doc
Manuscript File 7281-Review.doc
Answering Reviewers 7281-Answering reviewers.pdf
Copyright License Agreement 7281-Copyright assignment.pdf
Peer-review Report 7281-Peer reviews.pdf
Scientific Editor Work List 7281-Scientific editor work list.doc